SupplementDrug
Arabinose clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
University of Copenhagen (2) · Integrative Health Technologies, Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Arabinose is read from its arms, and is right about nine times in ten.
Testing it · 3
- The Effects of L-arabinose on Intestinal Sucrase Activity in ManCompletedPhase 1University of CopenhagenNCT00302302Written as L-arabinose
- The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in ManCompletedNot applicableUniversity of CopenhagenNCT01957098Written as Active comparator: 8% L-arabinose
- Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and InsulinCompletedNot applicableIntegrative Health Technologies, Inc.NCT01107431Written as L-Arabinose and Chromium
Codes
What other systems call Arabinose · ClinicalTrials.gg INT007017
- MeSH (NLM) D001089ArabinoseConfirmed NLM, Wikidata
- UNII (FDA) B40ROO395ZARABINOSE, L-Confirmed NLM, Wikidata
- Wikidata Q407373aldehydo-L-arabinoseConfirmed NLM, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001089 | Arabinose | Confirmed NLM, Wikidata |
| UNII (FDA) | B40ROO395Z | ARABINOSE, L- | Confirmed NLM, Wikidata |
| Wikidata | Q407373 | aldehydo-L-arabinose | Confirmed NLM, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.